Regimen Simplification to Atazanavir‐Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48‐Week Clinical and Virologic Outcomes
- Wilkin, Timothy J.
- McKinnon, John E.
- DiRienzo, A. Gregory
- Mollan, Katie
- Fletcher, Courtney V.
- Margolis, David M.
- Bastow, Barbara
- Thal, Gary
- Woodward, William
- Godfrey, Catherine
- Wiegand, Ann
- Maldarelli, Frank
- Palmer, Sarah
- Coffin, John M.
- Mellors, John W.
- Swindells, Susan
Publication date
January 2009
DOIAbstract
Simplified maintenance therapy with ritonavir-boosted atazanavir (ATV/RTV) alone is attractive because of nucleoside reverse-transcriptase inhibitor (NRTI)–sparing benefits, low pill burden, once-daily dosage, and safety
Add to ORKG